NXTC - NextCure, Inc.
IEX Last Trade
0.831
-0.038 -4.573%
Share volume: 18
Last Updated: Fri 27 Dec 2024 05:24:03 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.39%
PREVIOUS CLOSE
CHG
CHG%
$0.87
-0.04
-4.37%
Summary score
9%
Profitability
0%
Dept financing
3%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-4.61%
Return on assets
-4.35%
Return on sales
0%
Return on invested capital
-340.33%
Total debt ratio
14.18%
Debt ratio change over timeo
-1.06%
Current Ratio
21.02%
Quick Ratio
0%
Cash Position Ratio
7.19%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-4.28%
Return on assets
-4.28%
Return on sales
0%
Return on invested capital
-453.58%
Total debt ratio
10%
Debt ratio change over timeo
-1.05%
Current Ratio
25.1%
Quick Ratio
0%
Cash Position Ratio
2.16%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-4.51%
Return on assets
-4.74%
Return on sales
0%
Return on invested capital
-144.26%
Total debt ratio
3.47%
Debt ratio change over time
-1%
Current Ratio
37.68%
Quick Ratio
0%
Cash Position Ratio
3.2%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-98.14%
Return on assets
-98.23%
Return on sales
0%
Return on invested capital
61.56%
Total debt ratio
-105.91%
Debt ratio change over time
-1.06%
Current Ratio
-8.93%
Quick Ratio
0%
Cash Position Ratio
-3.83%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NXTC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.61% | -3.05% | 11.55% | 6.27% |
| Return on assets | -4.35% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -340.33% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 14.18% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -1.06% | 6.09% | 6.03% | 1.53% |
| Dept financing | 4% | 50% | 43% | 14% |
| Current Ratio | 25.1% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.16% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 15% | 31% | 32% |
| Short-term ratios | NXTC | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.28% | -25.62% | 17.94% | 7.14% |
| Return on assets | -4.28% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -453.58% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 10% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.05% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 25.1% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 2.16% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 36% | 26% | 46% |